Fondazione Università G. D'Annunzio; Clinical Research Center (CRC); Centro Studi (CESI)

Chieti, Abruzzo 66103

0 studies enrolling now · 1 studies all time

What they study most

Triple-Negative Breast Cancer

Studies at this site

• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) — Completed